|
Registered number: 09982274
Charity number: 1167706
SCREW CANCER LIMITED
(A company limited by guarantee)
UNAUDITED
TRUSTEES' REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026
|
|
SCREW CANCER LIMITED
(A company limited by guarantee)
CONTENTS
|
|
|
Reference and administrative details of the Company, its Trustees and advisers
|
|
|
|
|
Independent examiner's report
|
|
Statement of financial activities
|
|
|
|
|
Notes to the financial statements
|
|
|
|
SCREW CANCER LIMITED
(A company limited by guarantee)
REFERENCE AND ADMINISTRATIVE DETAILS OF THE COMPANY, ITS TRUSTEES AND ADVISERS
FOR THE YEAR ENDED 28 FEBRUARY 2026
|
|
|
|
|
|
|
|
|
|
|
Patrick Curtis Green (resigned 31 January 2026)
|
Company registered number
|
|
Charity registered number
|
|
|
|
270 Kings Road
London
SW3 5AW
|
|
|
NatWest
West End CBC
2nd Floor
180 Brompton Road
London
SW3 1HL
|
Page 1
|
|
SCREW CANCER LIMITED
(A company limited by guarantee)
TRUSTEES' REPORT
FOR THE YEAR ENDED 28 FEBRUARY 2026
The Trustees present their annual report together with the financial statements of the Company for the 1 March 2025 to 28 February 2026. The Annual report serves the purposes of both a Trustees' report and a directors' report under company law. The Trustees confirm that the Annual report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019).
Since the Company qualifies as small under section 382 of the Companies Act 2006, the Strategic report required of medium and large companies under the Companies Act 2006 (Strategic Report and Directors' Report) Regulations 2013 has been omitted.
Objectives and activities
a. Policies and objectives
The objective of the charity was to assist in the treatment and care of persons suffering from cancer.
b. Activities undertaken to achieve objectives
The principal activity of the charity was to create an individualised app for cancer patients to provide them with
important and relevant information in relation to their illness.
c. Main activities undertaken to further the Company's purposes for the public benefit
The Cancer App developed by the Charity continued to be provided to the public for free during the year.
Achievements and performance
a. Review of activities
Having completed the app and to ensure continued app user support, hosting and maintenance of all app software and compliant app content, the charity assigned the rights title and interest in the app to Interactive Pharma Solutions Limited (“IPS”) on 30 April 2024. IPS were commissioned by the charity to develop, manage and host the app. On 30 April 2024 IPS committed to finding ongoing support and funding for the app to keep the app free at the point of use for app users. The Trustees have continued to wind down the charity during this financial year.
Financial review
a. Going concern
After making appropriate enquiries the Trustees determined that the charity had insufficient funds to continue to support The Cancer App. As noted above The Cancer App was transferred to IPS in the expectation that they would continue to keep the app free at the point of use for app users. For this reason they have not adopted the going concern basis in preparing the financial statements.
b. Reserves policy
The Trustees have wound down the Charity during the year and as at 28 February 2026 had no assets, liabilities or reserves.
Page 2
|
|
SCREW CANCER LIMITED
(A company limited by guarantee)
Structure, governance and management
a. Constitution
The company is limited by guarantee governed by its Memorandum and Articles of Association dated 31 May
2016. It is registered as a Charity with the Charity Commission.
The company was incorporated on 2 February 2016. Its company registration number is 09982274.
b. Methods of appointment or election of Trustees
The management of the company is the responsibility of the Trustees who are elected and co-opted under the
terms of the Articles of Association. The following Trustees have held office during the reporting period:
- Mr C Orchard
- Mr M Fitch
- Ms C German
- Mr P Green (resigned on 31 January 2026)
c. Organisational structure and decision-making policies
All decisions are made by the Trustees.
d. Pay policy for key management personnel
No remuneration is paid to the Trustees.
Statement of Trustees' responsibilities
The Trustees (who are also the directors of the Company for the purposes of company law) are responsible for preparing the Trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
Company law requires the Trustees to prepare financial statements for each financial . Under company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:
∙select suitable accounting policies and then apply them consistently;
∙observe the methods and principles of the Charities SORP (FRS 102);
∙make judgments and accounting estimates that are reasonable and prudent;
∙state whether applicable UK Accounting Standards (FRS 102) have been followed, subject to any material departures disclosed and explained in the financial statements;
∙prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.
The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Approved by order of the members of the board of Trustees and signed on their behalf by:
Page 3
|
|
SCREW CANCER LIMITED
(A company limited by guarantee)
INDEPENDENT EXAMINER'S REPORT
FOR THE YEAR ENDED 28 FEBRUARY 2026
Independent examiner's report to the Trustees of Screw Cancer Limited ('the Company')
|
I report to the charity Trustees on my examination of the accounts of the Company for the year ended 28 February 2026.
Responsibilities and basis of report
|
As the Trustees of the Company (and its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').
Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the Company's accounts carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.
Independent examiner's statement
|
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:
|
|
accounting records were not kept in respect of the Company as required by section 386 of the 2006 Act; or
|
|
|
the accounts do not accord with those records; or
|
|
|
the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair' view which is not a matter considered as part of an independent examination; or
|
|
|
the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities [applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)].
|
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
This report is made solely to the Company's Trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. My work has been undertaken so that I might state to the Company's Trustees those matters I am required to state to them in an Independent examiner's report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the Company and the Company's Trustees as a body, for my work or for this report.
Signed: Scott McCullough FCA Dated: 5 August 2026
Scott McCullough FCA Chartered Accountants Ireland
Suite 2.06
Custom House
Custom House Square
Belfast
BT1 3ET
Page 4
|
|
SCREW CANCER LIMITED
(A company limited by guarantee)
STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT)
FOR THE YEAR ENDED 28 FEBRUARY 2026
|
|
|
|
|
|
Total funds brought forward
|
|
|
|
|
|
|
|
|
|
|
Total funds carried forward
|
|
|
|
|
The Statement of financial activities includes all gains and losses recognised in the year.
|
The notes on pages 7 to 15 form part of these financial statements.
|
Page 5
|
|
SCREW CANCER LIMITED
(A company limited by guarantee)
REGISTERED NUMBER: 09982274
BALANCE SHEET
AS AT 28 FEBRUARY 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Creditors: amounts falling due within one year
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets less current liabilities
|
|
|
|
|
|
Net assets excluding pension asset
|
|
|
|
|
|
|
|
|
|
|
|
|
The Company was entitled to exemption from audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006.
The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.
The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime.
The financial statements were approved and authorised for issue by the Trustees and signed on their behalf by:
|
|
|
|
|
|
The notes on pages 7 to 15 form part of these financial statements.
|
Page 6
|
|
SCREW CANCER LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026
Screw Cancer Limited is registered as a charitable company limited by guarantee, incorporated in
England with company registration number 09982274. The company is registered with the Charity Commission with charity registration number 1167706.
The company is limited by guarantee governed by its Memorandum and Articles of Association dated 31 May 2016.
The registered office is situated at 270 Kings Road, London, SW3 5AW.
2.Accounting policies
|
|
|
Basis of preparation of financial statements
|
The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.
Screw Cancer Limited meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.
The accounts have not been prepared on a going concern basis. The Trustees are winding down the charity.
All income is recognised once the Company has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.
Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use.
Expenditure on charitable activities is incurred on directly undertaking the activities which further the Company's objectives, as well as any associated support costs.
All expenditure is inclusive of irrecoverable VAT.
Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.
Page 7
|
|
SCREW CANCER LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026
2.Accounting policies (continued)
|
|
|
Liabilities and provisions
|
Liabilities are recognised when there is an obligation at the Balance sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.
Liabilities are recognised at the amount that the Company anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.
Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Statement of financial activities as a finance cost.
The Company only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.
General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Company and which have not been designated for other purposes.
Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Company for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.
|
|
|
Income from charitable activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Page 8
|
|
SCREW CANCER LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026
|
|
|
Analysis of expenditure on charitable activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cancer treatment assistance
|
|
|
|
|
|
|
|
|
|
|
Cancer treatment assistance
|
|
|
|
|
|
|
Analysis of expenditure by activities
|
|
|
|
|
|
|
|
|
|
|
|
Activities undertaken directly
2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cancer treatment assistance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Activities undertaken directly
2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cancer treatment assistance
|
|
|
|
Page 9
|
|
SCREW CANCER LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026
5.Analysis of expenditure by activities (continued)
|
|
|
|
|
|
|
|
|
|
|
Cancer treatment assistance
2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
App Development and Hosting Costs
|
|
|
|
|
|
|
|
|
|
|
Cancer treatment assistance
2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
App Development and Hosting Costs
|
|
|
|
|
Analysis of support costs
|
|
|
|
|
|
|
|
|
Cancer treatment assistance
2026
|
|
|
|
|
|
|
Page 10
|
|
SCREW CANCER LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026
5.Analysis of expenditure by activities (continued)
Analysis of support costs (continued)
|
|
|
Cancer treatment assistance
2025
|
|
|
|
|
|
|
|
|
Independent examiner's remuneration
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fees payable to the Company's independent examiner for the independent examination of the Company's annual accounts
|
|
|
|
|
Fees payable to the Company's independent examiner in respect of:
|
|
|
|
|
All assurance services not included above
|
|
|
|
|
All other services not included above
|
|
|
|
|
Trustees' remuneration and expenses
|
|
|
During the year, no Trustees received any remuneration or other benefits (2025 - £NIL).
|
|
|
During the year ended 28 February 2026, no Trustee expenses have been incurred (2025 - £NIL).
|
Page 11
|
|
SCREW CANCER LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026
|
|
|
|
Creditors: Amounts falling due within one year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accruals and deferred income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial assets measured at fair value through income and expenditure
|
|
|
Financial assets measured at fair value through income and expenditure comprise of cash at bank.
Page 12
|
|
SCREW CANCER LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026
|
|
|
Statement of funds - current year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General Funds - all funds
|
|
|
Page 13
|
|
SCREW CANCER LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026
|
|
|
Statement of funds (continued)
|
|
|
|
Statement of funds - prior year
|
|
|
|
|
Balance at
1 March 2024
£
|
|
|
|
|
|
|
|
|
|
|
|
General Funds - all funds
|
|
|
|
|
|
|
|
|
|
|
|
Restricted Funds - all funds
|
|
|
|
|
|
|
Summary of funds - current year
|
|
|
|
|
|
|
|
|
|
Summary of funds - prior year
|
|
|
|
|
Balance at
1 March 2024
£
|
|
|
Page 14
|
|
SCREW CANCER LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026
|
|
|
Analysis of net assets between funds
|
|
|
|
Analysis of net assets between funds - current year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of net assets between funds - prior year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Creditors due within one year
|
|
|
|
|
|
|
|
|
|
Related party transactions
|
|
|
During the year, the charity engaged UHY Hacker Young Fitch Limited, Chartered Accountants, to provide professional services. Michael Fitch, one of the Trustees, is a director of the company. Fees for these services amounted to £581 (2025: £3,431).
|
Page 15
|